Rubin Martina, Preziosa Paolo, Margoni Monica, Meani Alessandro, Pagani Elisabetta, Corazzolla Gianluca, Storelli Loredana, Mistri Damiano, Filippi Massimo, Rocca Maria A
Neuroimaging Research Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele, Milano, Italy.
Neurology Unit, IRCCS Ospedale San Raffaele, Milano, Italy.
J Neurol Neurosurg Psychiatry. 2025 Apr 10;96(5):443-452. doi: 10.1136/jnnp-2024-334913.
Immune-mediated processes are implicated in the pathogenesis of fatigue, a common symptom in multiple sclerosis (MS). The choroid plexus (CP) regulates central nervous system (CNS) immune homeostasis and undergoes volumetric modifications possibly contributing to MS-related fatigue. We explored the association between MS-related CP volume changes and fatigue dynamics.
Eighty-five patients with MS and 68 healthy controls (HC) underwent brain 3T MRI, neurological evaluation and Modified Fatigue Impact Scale (MFIS) at two timepoints (median follow-up=1.4 years). Normalised brain and regional grey matter (GM) volumes were obtained using FSL-SIENAx, FIRST, SIENA and tensor-based morphometry. CP volumes were quantified with in-house methods, and longitudinal changes were analysed using linear mixed models.
At baseline, 25 (29%) patients with MS had fatigue (f-MS) (MFIS ≥38). Compared with HC, patients with MS had significantly higher brain T2-lesion volume, lower brain, deep GM, cortical volumes and higher CP volume (false discovery rate (FDR)-p ≤0.024). Compared with non-fatigued (nf-MS) patients, f-MS were older, more disabled (FDR-p ≤0.002) and showed numerically higher CP volume (FDR-p=0.076). At follow-up, 41 (68%) nf-MS remained non-fatigued (nf-FU-MS) and 19 (32%) developed fatigue (f-FU-MS). Patients with MS showed higher brain and deep GM atrophy rates versus HC (FDR-p ≤0.048), whereas clinical, lesional and brain volumetric changes were not significantly different among MS groups (FDR-p ≥0.287). CP volume significantly increased in all MS groups compared with HC (FDR-p ≤0.043), with greater enlargement in f-FU-MS versus nf-FU-MS (FDR-p=0.048).
Larger CP and greater enlargement are associated with the presence and development of fatigue in MS, likely reflecting dynamic inflammatory states within the CNS, supporting the immunological contribution to MS-related fatigue.
免疫介导过程与疲劳的发病机制有关,疲劳是多发性硬化症(MS)的常见症状。脉络丛(CP)调节中枢神经系统(CNS)的免疫稳态,并发生体积变化,这可能与MS相关的疲劳有关。我们探讨了MS相关的CP体积变化与疲劳动态之间的关联。
85例MS患者和68名健康对照(HC)在两个时间点(中位随访时间 = 1.4年)接受了脑部3T MRI、神经学评估和改良疲劳影响量表(MFIS)评估。使用FSL-SIENAx、FIRST、SIENA和基于张量的形态计量学获得标准化的脑和区域灰质(GM)体积。CP体积采用内部方法进行量化,并使用线性混合模型分析纵向变化。
在基线时,25例(29%)MS患者有疲劳症状(f-MS)(MFIS≥38)。与HC相比,MS患者的脑T2病变体积显著更高,脑、深部GM、皮质体积更低,CP体积更高(错误发现率(FDR)-p≤0.024)。与无疲劳症状(nf-MS)的患者相比,f-MS患者年龄更大,残疾程度更高(FDR-p≤0.002),CP体积在数值上更高(FDR-p = 0.076)。在随访时,41例(68%)nf-MS患者仍无疲劳症状(nf-FU-MS),19例(32%)出现疲劳症状(f-FU-MS)。与HC相比,MS患者的脑和深部GM萎缩率更高(FDR-p≤0.048),而MS组之间的临床、病变和脑体积变化无显著差异(FDR-p≥0.287)。与HC相比,所有MS组的CP体积均显著增加(FDR-p≤0.043),f-FU-MS组的CP体积增大幅度大于nf-FU-MS组(FDR-p = 0.048)。
更大的CP体积和更大的增大幅度与MS患者疲劳症状的存在和发展相关,可能反映了CNS内的动态炎症状态,支持免疫因素对MS相关疲劳的影响。